About Protein EVI2B
Protein EVI2B (EVI2B) is a protein
from Homo sapiens identified by UniProt accession
P34910, 448 residues long.
MolForge cross-references it against 0 known binders and
104 disease associations.
Target properties
| Protein name | Protein EVI2B |
| UniProt accession | P34910 |
| Gene | EVI2B |
| Organism | Homo sapiens |
| Length | 448 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (104)
Diseases linked to this target (Open Targets).
- neurofibromatosis type 1 · score 0.42
- neurodegenerative disease · score 0.28
- sex hormone-binding globulin measurement · score 0.21
- blood phosphate measurement · score 0.16
- hemorrhoid · score 0.15
- cystatin C measurement · score 0.15
- platelet count · score 0.15
- type 2 diabetes mellitus · score 0.14
- alcohol consumption measurement · score 0.14
- alkaline phosphatase measurement · score 0.14
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P34910-F1 | alphafold | PREDICTED | 50.93 | — |
Amino-acid sequence (448 residues)
MDPKYFILIL FCGHLNNTFF SKTETITTEK QSQPTLFTSS MSQVLANSQN TTGNPLGQPT QFSDTFSGQS ISPAKVTAGQ PTPAVYTSSE KPEAHTSAGQ PLAYNTKQPT PIANTSSQQA VFTSARQLPS ARTSTTQPPK SFVYTFTQQS SSVQIPSRKQ ITVHNPSTQP TSTVKNSPRS TPGFILDTTS NKQTPQKNNY NSIAAILIGV LLTSMLVAII IIVLWKCLRK PVLNDQNWAG RSPFADGETP DICMDNIREN EISTKRTSII SLTPWKPSKS TLLADDLEIK LFESSENIED SNNPKTEKIK DQVNGTSEDS ADGSTVGTAV SSSDDADLPP PPPLLDLEGQ ESNQSDKPTM TIVSPLPNDS TSLPPSLDCL NQDCGDHKSE IIQSFPPLDS LNLPLPPVDF MKNQEDSNLE IQCQEFSIPP NSDQDLNESL PPPPAELL
Explore Protein EVI2B with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets